Evaluation of a type 2 diabetes prevention program using a commercial weight management provider for nondiabetic hyperglycemic patients referred by primary care in the UK

BMJ Open Diabetes Research and Care

Volumn 5, Issue 1, 2017, Pages

  Piper, Carolyn ^a   Marossy, Agnes ^a   Griffiths, Zoe ^b   Adegboye, Amanda ^c  

^a London Borough of Bromley   (United Kingdom)

^b Weight Watchers ^*  (United Kingdom)

^c UNIVERSITY OF WESTMINSTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT MANAGEMENT; COHORT ANALYSIS; DIASTOLIC BLOOD PRESSURE; ETHNICITY; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HEALTH PROGRAM; HUMAN; HYPERGLYCEMIA; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PHYSICAL ACTIVITY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROPHYLAXIS; QUALITATIVE RESEARCH; QUASI EXPERIMENTAL STUDY; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

EID: 85032854425     PISSN: None     EISSN: 20524897     Source Type: Journal    
DOI: 10.1136/bmjdrc-2017-000418     Document Type: Article

References (29)

1. Public Health England. NHS Diabetes Prevention Programme (NHS DPP) non-diabetic hyperglycaemia. London: NCVIN, 2015. https://www.gov.uk/government/publications/nhs-diabetes-preventionprogramme-non-diabetic-hyperglycaemia. (accessed Dec 2016).
2. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393–403.
3. Yates T, Khunti K, Bull F, et al. The role of physical activity in the management of impaired glucose tolerance: a systematic review. Diabetologia 2007;50:1116–26.
4. King P, Peacock I, Donnelly R. The UK Prospective Diabetes Study (UKPDS): clinical and therapeutic implications for type 2 diabetes. Br J Clin Pharmacol 1999;48:643–8.
5. Clarke R, Emberson J, Fletcher A, et al. Life expectancy in relation to cardiovascular risk factors: 38 year follow-up of 19,000 men in the Whitehall study. BMJ 2009;339:b3513.
6. Public Health England. Diabetes prevalence model. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/612306/Diabetesprevalencemodelbriefing.pdf (accessed Sep 2016).
7. Lean ME. Obesity: burdens of illness and strategies for prevention or management. Drugs Today 2000;36:773–84.
8. Bombelli M, Facchetti R, Sega R, et al. Impact of body mass index and waist circumference on the long-term risk of diabetes mellitus, hypertension, and cardiac organ damage. Hypertension 2011;58:1029–35.
9. England PH. Prevalence estimates of non-diabetic hyperglycaemia. London: NCVIN, 2015. https://www.gov.uk/government/publications/nhs-diabetes-prevention-programme-non-diabetic-hyperglycaemia. (accessed Dec 2016).
10. Ashra NB, Spong R, Carter P, et al. A systematic review and meta-analysis assessing the effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes mellitus in routine practice. London: Public Health England, 2015. https://www.gov.uk/government/publications/diabetes-prevention-programmesevidence-review. (accessed Dec 2016).
11. Hamman RF, Wing RR, Edelstein SL, et al. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care 2006;29:2102–7.
12. Kramer MK, Venditti EM, Semler LN, et al. Long-term strategies for diabetes prevention: evaluation of the group lifestyle balance postcore sessions focusing on carbohydrate and hunger management. J Diabetes Metab 2012;S2:006.
13. Jolly K, Lewis A, Beach J, et al. Comparison of range of commercial or primary care led weight reduction programmes with minimal intervention control for weight loss in obesity: lighten Up randomised controlled trial. BMJ 2011;343:d6500.
14. National Institute for Health and Care Excellence. Weight management: lifestyle services for overweight or obese adults. NICE guidelines [PH53], 2014.
15. Marrero DG, Palmer KN, Phillips EO, et al. Comparison of commercial and self-initiated weight loss programs in people with prediabetes: a randomized control trial. Am J Public Health 2016;106:949–56.
16. Ogrinc G, Davies L, Goodman D, et al. SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process. BMJ Qual Safety 2015.
17. National Institute for Health and Care Excellence. Eating disorders: recognition and treatment. NICE clinical guideline [CG9], 2004.
18. Duijzer G, Haveman-Nies A, Jansen SC, et al. SLIMMER: a randomised controlled trial of diabetes prevention in Dutch primary health care: design and methods for process, effect, and economic evaluation. BMC Public Health 2014;14:602.
19. Department of Health. Putting prevention first. Vascular checks: risk assessment and management. 2008 http://www.healthcheck.nhs.uk/commissioners_and_providers/guidance/national_guidance1/ (accessed December 2016).
20. Bull FC and the Expert Working Groups. Physical activity guidelines in the UK: review and recommendations. School of Sport, Exercise and Health Sciences, Loughborough University, 2010. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/213743/dh_128255.pdf. (accessed Dec 2016).
21. World Health Organisation (2008). Waist circumference and waist-hip ratio. Report of a WHO expert consultation. 2003 http://apps.who.int/iris/bitstream/10665/44583/1/9789241501491_eng.pdf (accessed 11 Mar 2016).
22. Department for Communities and Local Government (2015). English indices of deprivation, official statistics. https://www.gov.uk/government/statistics/english-indices-of-deprivation-2015 (accessed Oct 2016).
23. World Health Organisation. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Abbreviated report of a WHO consultation. Geneva: WHO, 2011. http://www.who.int/diabetes/publications/report-hba1c_2011.pdf. (accessed Jan 2017).
24. Tabák AG, Herder C, Rathmann W, et al. Prediabetes: a high-risk state for developing diabetes. Lancet 2012;379:2279–90.
25. Wang Y, Rimm EB, Stampfer MJ, et al. Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr 2005;81:555–63.
26. Ratner R, Goldberg R, Haffner S, et al. Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program. Diabetes Care 2005;28:888–94.
27. Department of Health. Five year forward view. 2014 https://www.england.nhs.uk/wp-content/uploads/2014/10/5yfv-web.pdf (accessed Dec 2016).
28. Slama K, Karsenty S, Hirsch A. Effectiveness of minimal intervention by general practitioners with their smoking patients: a randomised, controlled trial in France. Tob Control 1995;4:162–9.
29. Mainous AG, Tanner RJ, Baker R, et al. Prevalence of prediabetes in England from 2003 to 2011: population-based, cross-sectional study. BMJ Open 2014;4:e005002.